Next Article in Journal
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
Previous Article in Journal
Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(4), 786; https://doi.org/10.3390/pharmaceutics14040786
Action Date Notes Link
article xml file uploaded 3 April 2022 12:35 CEST Original file -
article xml uploaded. 3 April 2022 12:35 CEST Update -
article pdf uploaded. 3 April 2022 12:35 CEST Version of Record https://www.mdpi.com/1999-4923/14/4/786/pdf-vor
article supplementary file uploaded. 3 April 2022 12:35 CEST - https://www.mdpi.com/1999-4923/14/4/786#supplementary
article html file updated 3 April 2022 12:36 CEST Original file -
article xml file uploaded 8 April 2022 07:10 CEST Update -
article xml uploaded. 8 April 2022 07:10 CEST Update https://www.mdpi.com/1999-4923/14/4/786/xml
article pdf uploaded. 8 April 2022 07:10 CEST Updated version of record https://www.mdpi.com/1999-4923/14/4/786/pdf
article html file updated 8 April 2022 07:12 CEST Update -
article html file updated 2 August 2022 17:12 CEST Update https://www.mdpi.com/1999-4923/14/4/786/html
Back to TopTop